About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05656404

TorEx Lung Perfusion System

Lung transplantation is a life-saving and life-prolonging therapy for patients with end-stage lung disease. However, the number of patients listed for lung transplantation exceeds the number of availa...

Lead sponsor: University Health Network, Toronto•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Health Network, Toronto

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Actively listed for primary lung transplantation
•Written, informed consent provided
•18-80 years old
•Age ≤70 years old
•Ex vivo lung perfusion clinically indicated for donor lungs

Exclusion Criteria

•Re-transplantation
•Multi-organ transplantation
•Participation in another interventional trial
•Age \>70 years old
•Donor lungs suitable to go straight to transplantation
•EVLP Transplant Suitability
•Pulmonary vein PO2 \> 400mmHg
•Stability or improvement of other lung function parameters during EVLP (PVR, Compliance, Airway Pressures)
•Surgeon clinically satisfied with lung evaluation

Related studies

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

NCT07516379 · Lung Transplant, End Stage Lung Disease, and more

RECRUITINGEARLY Phase 1

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

NCT04469842 · Lung Transplant; Complications

RECRUITINGPhase 2

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

NCT06476132 · Lung Transplant

RECRUITINGPhase 1

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

NCT06770023 · Lung Transplant, Pulmonary Hypertension

RECRUITINGPhase 2

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

NCT07046910 · Lung Transplant Rejection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 6, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment20

Start dateDec 2022

Last updatedDec 6, 2024

Condition

Lung Transplant Ex Vivo Lung Perfusion

Locations shown

Toronto General Hospital, University Health Network

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 6, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions